A single intramuscular injection of monoclonal antibody MAD0004J08 induces in healthy adults SARS-CoV-2 neutralising antibody titres exceeding those induced by infection and vaccination
View ORCID ProfileSimone Lanini, Stefano Milleri, View ORCID ProfileEmanuele Andreano, Sarah Nosari, View ORCID ProfileIda Paciello, View ORCID ProfileGiulia Piccini, Alessandra Gentili, Adhuna Phogat, View ORCID ProfileInesa Hyseni, View ORCID ProfileMargherita Leonardi, View ORCID ProfileAlessandro Torelli, View ORCID ProfileEmanuele Montomoli, Andrea Paolini, Andrea Frosini, View ORCID ProfileAndrea Antinori, View ORCID ProfileEmanuele Nicastri, View ORCID ProfileEnrico Girardi, View ORCID ProfileMaria Maddalena Plazzi, View ORCID ProfileGiuseppe Ippolito, Francesco Vaia, Giovanni Della Cioppa, View ORCID ProfileRino Rappuoli
doi: https://doi.org/10.1101/2021.08.03.21261441
Simone Lanini
1Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani – IRCCS, Rome, Italy
Stefano Milleri
2Centro Ricerche Cliniche di Verona, University and Hospital Trust of Verona, Verona, Italy
Emanuele Andreano
3Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy
Sarah Nosari
4AchilleS Vaccine, Siena, Italy
Ida Paciello
3Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy
Giulia Piccini
5VisMederi S.r.l, Siena, Italy
Alessandra Gentili
7CROss Research, Mendrisio, Switzerland
Adhuna Phogat
8Fondazione Toscana Life Sciences, Siena, Italy
Inesa Hyseni
5VisMederi S.r.l, Siena, Italy
6VisMederi Research S.r.l, Siena, Italy
Margherita Leonardi
5VisMederi S.r.l, Siena, Italy
6VisMederi Research S.r.l, Siena, Italy
Alessandro Torelli
5VisMederi S.r.l, Siena, Italy
Emanuele Montomoli
5VisMederi S.r.l, Siena, Italy
6VisMederi Research S.r.l, Siena, Italy
10Department of Molecular and Developmental Medicine, University of Siena, Siena, Italy
Andrea Paolini
8Fondazione Toscana Life Sciences, Siena, Italy
9Toscana Life Sciences Sviluppo, Siena, Italy
Andrea Frosini
8Fondazione Toscana Life Sciences, Siena, Italy
Andrea Antinori
1Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani – IRCCS, Rome, Italy
Emanuele Nicastri
1Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani – IRCCS, Rome, Italy
Enrico Girardi
1Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani – IRCCS, Rome, Italy
Maria Maddalena Plazzi
1Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani – IRCCS, Rome, Italy
Giuseppe Ippolito
1Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani – IRCCS, Rome, Italy
Francesco Vaia
1Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani – IRCCS, Rome, Italy
Giovanni Della Cioppa
11Clinical R&D Consultants, Rome, Italy
Rino Rappuoli
3Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy
12Department of Biotechnology, Chemistry and Pharmacy, University of Siena, Siena, Italy
Data Availability
All metadata generated in this analysis will be available.
Posted August 04, 2021.
A single intramuscular injection of monoclonal antibody MAD0004J08 induces in healthy adults SARS-CoV-2 neutralising antibody titres exceeding those induced by infection and vaccination
Simone Lanini, Stefano Milleri, Emanuele Andreano, Sarah Nosari, Ida Paciello, Giulia Piccini, Alessandra Gentili, Adhuna Phogat, Inesa Hyseni, Margherita Leonardi, Alessandro Torelli, Emanuele Montomoli, Andrea Paolini, Andrea Frosini, Andrea Antinori, Emanuele Nicastri, Enrico Girardi, Maria Maddalena Plazzi, Giuseppe Ippolito, Francesco Vaia, Giovanni Della Cioppa, Rino Rappuoli
medRxiv 2021.08.03.21261441; doi: https://doi.org/10.1101/2021.08.03.21261441
A single intramuscular injection of monoclonal antibody MAD0004J08 induces in healthy adults SARS-CoV-2 neutralising antibody titres exceeding those induced by infection and vaccination
Simone Lanini, Stefano Milleri, Emanuele Andreano, Sarah Nosari, Ida Paciello, Giulia Piccini, Alessandra Gentili, Adhuna Phogat, Inesa Hyseni, Margherita Leonardi, Alessandro Torelli, Emanuele Montomoli, Andrea Paolini, Andrea Frosini, Andrea Antinori, Emanuele Nicastri, Enrico Girardi, Maria Maddalena Plazzi, Giuseppe Ippolito, Francesco Vaia, Giovanni Della Cioppa, Rino Rappuoli
medRxiv 2021.08.03.21261441; doi: https://doi.org/10.1101/2021.08.03.21261441
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (671)
- Anesthesia (181)
- Cardiovascular Medicine (2660)
- Dermatology (224)
- Emergency Medicine (401)
- Epidemiology (12261)
- Forensic Medicine (10)
- Gastroenterology (765)
- Genetic and Genomic Medicine (4122)
- Geriatric Medicine (387)
- Health Economics (681)
- Health Informatics (2668)
- Health Policy (1007)
- Hematology (364)
- HIV/AIDS (855)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (440)
- Neurology (3908)
- Nursing (210)
- Nutrition (580)
- Oncology (2043)
- Ophthalmology (587)
- Orthopedics (242)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1116)
- Primary Care Research (453)
- Public and Global Health (6548)
- Radiology and Imaging (1407)
- Respiratory Medicine (871)
- Rheumatology (411)
- Sports Medicine (343)
- Surgery (452)
- Toxicology (54)
- Transplantation (186)
- Urology (167)